Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland

Merck, invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development Responds to global demand for biosafety testing for drug development and commercialization Expansion creates nearly 500 new jobs in Glasgow and Stirling Company’s investment to boost global testing capacity now [...]

SOPHiA GENETICS Announces Nomination of Lila Tretikov to Board of Directors

Microsoft’s Deputy Chief Technology Officer to be appointed at Annual Shareholders’ Meeting BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the nomination of Lila Tretikov to its Board of Directors. The Board of Directors has proposed the appointment of Tretikov [...]

Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies

Seer’s Proteograph XT pushes the boundaries of biological discovery by enabling rapid proteomics across a range of sample types and species with unprecedented resolution and scale REDWOOD CITY, Calif. -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced the launch of the Proteograph XT Assay Kit, [...]

10x Genomics Files Two New Lawsuits Requesting Preliminary Injunctions Against NanoString’s CosMx Products

Also Files New Suit Against Vizgen's MERSCOPE Products for Patent Infringement PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it filed new patent litigation against NanoString Technologies, Inc. (Nasdaq: NSTG) and Vizgen, Inc. in the European Unified Patent Court. 10x Genomics' new lawsuits allege that [...]

Nanologica Delivers Silica to Latin-American Customer for Production of Insulin

As a result of Nanologica's product in preparative chromatography, NLAB Saga®, reaching internal quality requirements, silica is now delivered to a customer in Latin America for production of diabetes drugs. The customer is a latin-american pharmaceutical manufacturer that manufactures, among other things, insulin and insulin analogues. This delivery refers to silica for the production of [...]

SOPHiA GENETICS Joins CancerX to Help Accelerate Cancer Research

As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced today at ASCO that it has  joined as a founding member of CancerX, a new public-private partnership [...]

Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research

Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics’ NGS platforms. The territory is worldwide, and the field is oncology and cancer research. Under the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and [...]

Illumina’s Board of Directors elects two experienced Independent Directors to Board

Stephen P. MacMillan, Hologic CEO, named non-executive Chair of Illumina's Board Scott B. Ullem, CFO of Edwards Lifesciences, also named to Board SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of governance changes consistent with the goal of enhancing long-term shareholder value. The Board has [...]

Genovis launch Innovative IgM-Specific Protease with Wide-Ranging Applications in Life Science Markets

As a leading innovator in the field of enzyme technology, Genovis today announces the launch of its cutting-edge IgM-specific protease. This highly efficient and specific enzyme holds significant potential within various life science sectors, including research, diagnostics and therapeutic applications. The newly developed IgM-specific protease demonstrates a remarkable level of effectiveness, exhibiting exceptional specificity towards [...]

Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells

– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments – – Landmark research project is 100x larger than existing efforts – – Data will be generated from thousands of patients across multiple cancers – – University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, [...]

Access IBO on Knowledge Center